Journal of Bone and Mineral Research · 2017 · 76 citations · 20 references
Life SciencesGeneticsMolecular GeneticsBiochemical GeneticsHuman GeneticsMedical GeneticsEnzyme DeficienciesInborn Errors Of MetabolismMetabolic Pathway DefectsVitamin D DeficiencyVitamin D DisordersVitamin D MetabolismEnzymesGenetic Disorders Of Vitamin MetabolismHepatic Vitamin D MetabolismHereditary Vitamin D-dependent RicketsLoss-of-function MutationsMineral Metabolism DisordersVitamin D InsufficiencyVitamin Metabolism Disorders
ABSTRACT Vitamin D requires a two-step activation by hydroxylation: The first step is catalyzed by hepatic 25-hydroxylase (CYP2R1, 11p15.2) and the second one is catalyzed by renal 1α-hydroxylase (CYP27B1, 12q13.1), which produces the active hormonal form of 1,25-(OH)2D. Mutations of CYP2R1 have been associated with vitamin D–dependent rickets type 1B (VDDR1B), a very rare condition that has only been reported to affect 4 families to date. We describe 7 patients from 2 unrelated families who presented with homozygous loss-of-function mutations of CYP2R1. Heterozygous mutations were present in their normal parents. We identified a new c.124_138delinsCGG (p.Gly42_Leu46delinsArg) variation and the previously published c.296T>C (p.Leu99Pro) mutation. Functional in vitro studies confirmed loss-of-function enzymatic activity in both cases. We discuss the difficulties in establishing the correct diagnosis and the specific biochemical pattern, namely, very low 25-OH-D suggestive of classical vitamin D deficiency, in the face of normal/high concentrations of 1,25-(OH)2D. Siblings exhibited the three stages of rickets based on biochemical and radiographic findings. Interestingly, adult patients were able to maintain normal mineral metabolism without vitamin D supplementation. One index case presented with a partial improvement with 1alfa-hydroxyvitamin D3 or alfacalcidol (1α-OH-D3) treatment, and we observed a dramatic increase in the 1,25-(OH)2D serum concentration, which indicated the role of accessory 25-hydroxylase enzymes. Lastly, in patients who received calcifediol (25-OH-D3), we documented normal 24-hydroxylase activity (CYP24A1). For the first time, and according to the concept of personalized medicine, we demonstrate dramatic improvements in patients who were given 25-OH-D therapy (clinical symptoms, biochemical data, and bone densitometry). In conclusion, the current study further expands the CYP2R1 mutation spectrum. We note that VDDR1B could be easily mistaken for classical vitamin D deficiency. © 2017 American Society for Bone and Mineral Research.
20
De-orphanization of Cytochrome P450 2R1
Jeffrey B. Cheng, Daniel Motola, David J. Mangelsdorf et al. · Journal of Biological Chemistry · 2003 · 405 citations · Full text
Martin Kaufmann, John C. Gallagher, Munro Peacock et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 249 citations · Full text
Vitamin D Metabolites and Bone Mineralization in Man*
P Bordier, Howard Rasmussen, Pierre J. Marie et al. · The Journal of Clinical Endocrinology & Metabolism · 1978 · 194 citations